Lv51
1270 积分 2021-10-06 加入
Realignment of clinical research after the COVID-19 era
14天前
已完结
Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment
2个月前
已完结
Targeting IL-17A to combat immune-related adverse events
2个月前
已完结
[New biological and targeted therapies for the management of immune-related adverse events]
2个月前
已完结
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
2个月前
已完结
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases
2个月前
已完结
The treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors with biologic therapy: A single-institution retrospective study at a tertiary care cancer center
2个月前
已完结
The Prevalence and Burden of Disorders of Gut-Brain Interaction (DGBI) before versus after the COVID-19 Pandemic
3个月前
已关闭
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion
4个月前
已关闭
Cutaneous infections presenting with granulomatous infiltrates: a review of histopathological patterns
5个月前
已完结
皖公网安备34019202002308
